Exhibit 23.1
EXHIBIT 23.1
CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS
We hereby consent to the use in this Registration Statement on Form SB-2 of
our report, dated November 8, 2000, except for the fifth paragraph of Note 5, as
to which the date is November 30, 2000, which includes an emphasis paragraph
relating to an uncertainty as to the Company's ability to continue as a going
concern on the restated consolidated financial statements of Meditech
Pharmaceuticals, Inc. and subsidiary. We also consent to the reference to our
Firm under the caption "Experts" in the Prospectus.
SINGER LEWAK GREENBAUM & GOLDSTEIN LLP
Los Angeles, California
December 5, 2000
